Target Identification/ Validation News for November 2013

Researchers Solve a Mystery about Type 2 Diabetes Drug with Assistance from AB SCIEX Mass Spectrometry Technologies Researchers Solve a Mystery about Type 2 Diabetes Drug with Assistance from AB SCIEX Mass Spectrometry Technologies

Researchers from St. Vincent’s Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding. The research is published in this month’s issue of the journal Nature Medicine.
23 November, 2013